Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Plan B CARE Program Tries To Take Rx Risk Management Over-The-Counter

Executive Summary

The Convenient Access, Responsible Education (CARE) program for Plan B underscores the complexities of translating risk management tools for prescription products to the over-the-counter setting
Advertisement

Related Content

FDA Plans Behind-The-Counter Meeting, Mulls “Transitional” Status
FDA Plans Behind-The-Counter Meeting, Mulls “Transitional” Status
Risk Management Could Bolster FDA Behind-The-Counter Switches – Gottlieb
The Third Way? Von Eschenbach Promotes Behind-The-Counter Drug Class
The Third Way? Von Eschenbach Promotes Behind-The-Counter Drug Class
Plan B Approval Clears The Way For Von Eschenbach Confirmation
Plan B Approval Clears The Way For Von Eschenbach Confirmation
Tysabri Out Of Remission; Returns With Updated Indication, Risk Management
FDA Requires Multiple Reports On New Accutane Risk Management Program
Advertisement
UsernamePublicRestriction

Register

PS047566

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel